Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
about
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).
@en
Lenalidomide in combination wi ...... ts of a phase 2 clinical trial
@nl
type
label
Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).
@en
Lenalidomide in combination wi ...... ts of a phase 2 clinical trial
@nl
prefLabel
Lenalidomide in combination wi ...... 2 clinical trial (OSHO-#077).
@en
Lenalidomide in combination wi ...... ts of a phase 2 clinical trial
@nl
P2093
P2860
P1476
Lenalidomide in combination wi ...... e 2 clinical trial (OSHO-#077)
@en
P2093
Andreas Schwarzer
Brigitte Kragl
Cornelia Becker
Cornelia Winkelmann
Dietger Niederwieser
Dietrich Gläser
Franz Albert Hoffmann
Jens Uhlig
Juliane Beck
Lars-Olof Mügge
P2860
P2888
P304
P356
10.1007/S00432-017-2504-5
P577
2017-08-21T00:00:00Z